CRMD - יחס חוב להיוון בספרים CorMedix Inc

CorMedix Inc. (CRMD) is protected by unique patents for catheter antiseptics, which blocks competitors under strict FDA oversight. This chart reflects a current share price of 0.31, while the company is betting on organic growth and the search for distribution partners. The business remains independent of economic cycles, relying instead on certification cycles for dialysis infection prevention tools.

Investors are assessing the potential of CorMedix Inc. (CRMD) through the lens of debt load, where the debt-to-equity ratio determines the business's financial stability. By analyzing the current debt-to-equity ratio, one can understand how effectively strategic alliances with dialysis centers are funded through leverage, which characterizes the company as a high-risk asset with significant leverage.